Cite
Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
MLA
Francesco Saverio Mennini, et al. “Cost-Effectiveness Analysis of Vaborem in Carbapenem-Resistant Enterobacterales (CRE) -Klebsiella Pneumoniae Infections in Italy.” Health Economics Review, vol. 11, no. 1, Oct. 2021, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13561-021-00341-z.
APA
Francesco Saverio Mennini, Mario Gori, Ioanna Vlachaki, Francesca Fiorentino, Paola La Malfa, Duccio Urbinati, & Massimo Andreoni. (2021). Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy. Health Economics Review, 11(1), 1–10. https://doi.org/10.1186/s13561-021-00341-z
Chicago
Francesco Saverio Mennini, Mario Gori, Ioanna Vlachaki, Francesca Fiorentino, Paola La Malfa, Duccio Urbinati, and Massimo Andreoni. 2021. “Cost-Effectiveness Analysis of Vaborem in Carbapenem-Resistant Enterobacterales (CRE) -Klebsiella Pneumoniae Infections in Italy.” Health Economics Review 11 (1): 1–10. doi:10.1186/s13561-021-00341-z.